parkinson造句
31. Objective To assess the efficacy of phase-weighted imaging in differentiating multiple system atrophy (MSA) from idiopathic Parkinson disease (IPD).
32. The three-month, multi-center study in Japan involved 279 Parkinson disease patients who weren't responding well to the commonly used drug, levodopa, to manage their symptoms.
33. Parkinson s disease(PD), is a progressively neurodegenerative disorder, resulting from the degeneration and loss of dopaminergic neurons in the substantia nigra of midbrain.
34. Parkinson′s disease(PD) is a degenerative disorder of the central nervous system characterized by neurodegeneration of dopaminergic neurons of the substantia nigra.
35. OBJECTIVE To study the substantia nigra apoptosis in Parkinson disease (PD) model rats and the nigra neurons protective effect of resveratrol.
36. The saccadic movement of patients with Parkinson s disease was abnormal and might be related to the severity of the disease.
37. Neurosurgery in Parkinson disease: A distressed mind in a repaired body?
38. We will put the suit aside for you, Mr. Parkinson.
39. Objective To study the effect of taurine on the living and growth of transplanted cells in Parkinson disease (PD) rat models after fetal mesencephalon cells transplantation.
40. Objective:To observe the effects of RSZZW combined with Madopar on substantia nigra and striatum TH-positive neurons in Parkinson disease rats.
41. Conclusion :There are certain scientific basis and possibility for applying chrono- physical therapy into promoting Parkinson patient's rehabilitation.
42. Arimatsu economic timber , Parkinson , Chatham , Betula, Tilia, Green and other species.
43. He suffers from Parkinson 's disease and arthritis. Hence, he is almost immobile.
44. AIM: To prepare the Parkinson disease models in rats with meperidine hydrochloride,[http:///parkinson.html] and measure the neural biochemical reaction in serum.
45. Results: We identified 126 incident Parkinson disease patients treated with levodopa for at least 2 months.
46. Historians have found evidence of the disease as far back as 5000 BC It was first described as "the shaking palsy" in 1817 by British doctor James Parkinson.
47. Till now, It has Parkinson disease families is SCA 2 families in Taiwan.
48. Objective To describe the technical approach and assess the efficacy and safety of deep brain stimulation (DBS) of the subthalamic nucleus (STN) in Parkinson disease (PD).
49. Objective:To observe the clinical efficacy of Kangzhen Zhijing capsule combined with Glutathione and its effect on blood antioxidase in parkinson s disease(PD) patients.
50. Parkinson who began research on sound transmission through ducts with acoustical material lining, questions of calculating sound attenuation by the dissipative mufflers have been ta...
51. AIM : To study the changes in the levels of monoamine neurotransmitter in plasma Parkinson disease ( PD ) .
52. The most common speech disorder of parkinson s disease is hypokinetic dysarthria.
53. Conclusion Rotenone injected subcutaneously in back is an effective method to reproduce the Parkinson disease model in rats.
54. Conclusion Microelectrode guided stereotactic pallidotomy and thalamotomy are effective measures for the treatment of Parkinson′s disease, but probably may bring about serious complications.
12